These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26661231)
21. Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption. Foley CP; Rubin DG; Santillan A; Sondhi D; Dyke JP; Crystal RG; Gobin YP; Ballon DJ J Control Release; 2014 Dec; 196():71-78. PubMed ID: 25270115 [TBL] [Abstract][Full Text] [Related]
22. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648 [TBL] [Abstract][Full Text] [Related]
23. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82. Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564 [TBL] [Abstract][Full Text] [Related]
24. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate. Preston E; Slinn J; Vinokourov I; Stanimirovic D J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299 [TBL] [Abstract][Full Text] [Related]
25. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brown RC; Egleton RD; Davis TP Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006 [TBL] [Abstract][Full Text] [Related]
26. Hyperammonemia-induced cytotoxic brain edema under osmotic opening of blood-brain barrier in dogs. Fujiwara M; Watanabe A; Shiota T; Yamauchi Y; Nakatsukasa H; Takei N; Kobayashi K; Higashi T; Nagashima H Res Exp Med (Berl); 1985; 185(6):425-7. PubMed ID: 3937190 [TBL] [Abstract][Full Text] [Related]
27. Iatrogenic arterial spasm relieved by intraarterial mannitol infusion. Fortin D; Osztie E; Neuwelt EA AJNR Am J Neuroradiol; 2000 May; 21(5):968-70. PubMed ID: 10815679 [TBL] [Abstract][Full Text] [Related]
28. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor. Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731 [TBL] [Abstract][Full Text] [Related]
29. Opening of blood-brain barrier in Triturus cristatus carnifex by hyperosmolar mannitol solutions. Franceschini V; Ciani F; Lazzari M; Del Grande P; Minelli G Basic Appl Histochem; 1988; 32(3):327-32. PubMed ID: 3147653 [TBL] [Abstract][Full Text] [Related]
30. [Intra-arterial ACNU, CDDP chemotherapy for brain metastases from lung cancer: comparison of cases with and without intra-arterial mannitol infusion]. Iwadate Y; Namba H; Saegusa T; Sueyoshi K No Shinkei Geka; 1993 Jun; 21(6):513-8. PubMed ID: 8336809 [TBL] [Abstract][Full Text] [Related]
31. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats. Pan GY; Liu XD; Liu GQ Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668 [TBL] [Abstract][Full Text] [Related]
32. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry. Adam JF; Biston MC; Joubert A; Charvet AM; Le Bas JF; Estève F; Elleaume H Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1173-82. PubMed ID: 15752899 [TBL] [Abstract][Full Text] [Related]
33. Effect of hyperosmotic solutions on human brain tumour vasculature. Sato S; Kawase T; Harada S; Takayama H; Suga S Acta Neurochir (Wien); 1998; 140(11):1135-41; disc 1141-2. PubMed ID: 9870058 [TBL] [Abstract][Full Text] [Related]
34. Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas. Heimberger K; Samec P; Binder H; Podreka I; Reisner T; Deecke L; Horaczek A; Dittrich C; Steger G; Zimpfer M Acta Radiol Suppl; 1986; 369():223-6. PubMed ID: 2980457 [TBL] [Abstract][Full Text] [Related]
35. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Nagy Z; Peters H; Hüttner I Lab Invest; 1984 Mar; 50(3):313-22. PubMed ID: 6422163 [TBL] [Abstract][Full Text] [Related]
36. Intra-arterial infusions of drugs and hyperosmotic solutions as ways of enhancing CNS chemotherapy. Fenstermacher J; Gazendam J Cancer Treat Rep; 1981; 65 Suppl 2():27-37. PubMed ID: 7346144 [TBL] [Abstract][Full Text] [Related]
37. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]. Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082 [TBL] [Abstract][Full Text] [Related]
38. Osmotic blood-brain barrier disruption in the posterior fossa of the dog. Neuwelt EA; Glasberg M; Diehl J; Frenkel EP; Barnett P J Neurosurg; 1981 Nov; 55(5):742-8. PubMed ID: 6796658 [TBL] [Abstract][Full Text] [Related]
39. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain. Chen KB; Wei VC; Yen LF; Poon KS; Liu YC; Cheng KS; Chang CS; Lai TW Neuroreport; 2013 Apr; 24(6):303-7. PubMed ID: 23426109 [TBL] [Abstract][Full Text] [Related]
40. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Shin BJ; Burkhardt JK; Riina HA; Boockvar JA Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]